Sale!

UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the UQCC2 gene responsible for mitochondrial complex III deficiency. This specialized test utilizes next-generation sequencing technology to detect nuclear type 7 mitochondrial disorders, providing crucial diagnostic information for patients experiencing unexplained metabolic symptoms. The test is particularly valuable for individuals with neurological deterioration, muscle weakness, exercise intolerance, and developmental delays. By identifying specific genetic mutations, healthcare providers can develop targeted treatment strategies and provide accurate genetic counseling. The test costs $500 USD and offers significant benefits including early intervention opportunities, family planning guidance, and personalized medical management. Results are typically available within 3-4 weeks from sample collection.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test

Comprehensive Genetic Testing for Mitochondrial Disorders

The UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying rare metabolic disorders affecting mitochondrial function. Mitochondrial complex III deficiency is a severe condition that disrupts cellular energy production, leading to progressive neurological and muscular deterioration. This specialized test specifically targets the UQCC2 gene, which plays a critical role in the assembly and stability of mitochondrial complex III – an essential component of the electron transport chain responsible for generating cellular energy.

What This Advanced Genetic Test Detects

Our NGS-based genetic test provides comprehensive analysis of the UQCC2 gene to identify pathogenic variants associated with mitochondrial complex III deficiency nuclear type 7. The test specifically examines:

  • Point mutations, deletions, and insertions in the UQCC2 gene
  • Variants affecting mitochondrial complex III assembly
  • Genetic changes impacting cellular energy metabolism
  • Inheritance patterns for genetic counseling purposes
  • Specific mutations linked to nuclear type 7 mitochondrial deficiency

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with symptoms suggestive of mitochondrial complex III deficiency, including:

  • Progressive neurological deterioration in infancy or childhood
  • Muscle weakness and exercise intolerance
  • Developmental delays and regression of motor skills
  • Lactic acidosis and metabolic crises
  • Failure to thrive in infants and children
  • Family history of mitochondrial disorders
  • Unexplained metabolic encephalopathy
  • Cardiomyopathy or cardiac involvement

Significant Benefits of Genetic Testing

Undergoing the UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test provides numerous advantages for patients and families:

  • Accurate Diagnosis: Provides definitive identification of the underlying genetic cause
  • Early Intervention: Enables timely medical management and treatment planning
  • Family Planning: Offers crucial information for reproductive decision-making
  • Personalized Treatment: Guides development of targeted therapeutic approaches
  • Genetic Counseling: Supports informed family discussions about inheritance risks
  • Prognostic Information: Helps predict disease progression and outcomes

Understanding Your Genetic Test Results

Our comprehensive genetic testing provides detailed results that require professional interpretation by genetic specialists:

  • Positive Result: Indicates the presence of pathogenic UQCC2 gene variants associated with mitochondrial complex III deficiency
  • Negative Result: Suggests no detectable mutations in the UQCC2 gene, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

All results are accompanied by detailed explanations and recommendations for follow-up care from our genetic counseling team.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have comprehensive testing facilities across the United States, with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality genetic testing with rapid turnaround times of 3-4 weeks.

Take Control of Your Genetic Health Today

Don’t let uncertainty about mitochondrial disorders affect your quality of life. Our UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test provides the clarity and answers you need for informed healthcare decisions. With our discounted price of $500 USD and comprehensive genetic analysis, you can access world-class diagnostic testing without financial burden.

Book your genetic test today by calling our dedicated genetic counseling team at +1(267) 388-9828 or schedule your appointment online. Take the first step toward understanding your genetic health and securing personalized medical care.